Cyclic peptide inhibitors of hepatitis C virus replication

Details for Australian Patent Application No. 2010298028 (hide)

Owner Intermune, Inc.

Inventors Buckman, Brad; Nicholas, John B.; Beigelman, Leonid; Serebryany, Vladimir; Stoycheva, Antitsa Dimitrova; Thrailkill, Timothy; Seiwert, Scott D.

Agent Davies Collison Cave

Pub. Number AU-A-2010298028

PCT Pub. Number WO2011/038293

Priority 61/346,238 19.05.10 US; 61/324,251 14.04.10 US; 61/345,737 18.05.10 US; 61/246,465 28.09.09 US

Filing date 24 September 2010

Wipo publication date 31 March 2011

International Classifications

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/038293 Priority application(s): WO2011/038293

4 October 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 and 06 Sep 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010298031-Method for presenting user-defined menu of digital content choices, organized as ring of icons surrounding preview pane

2010298026-Injectable hydrogel filaments for biomedical uses